CN105341929A - Health-care food composition capable of alleviating asthenopia - Google Patents
Health-care food composition capable of alleviating asthenopia Download PDFInfo
- Publication number
- CN105341929A CN105341929A CN201510874513.XA CN201510874513A CN105341929A CN 105341929 A CN105341929 A CN 105341929A CN 201510874513 A CN201510874513 A CN 201510874513A CN 105341929 A CN105341929 A CN 105341929A
- Authority
- CN
- China
- Prior art keywords
- health
- food composition
- care food
- alpha
- linolenic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 208000003464 asthenopia Diseases 0.000 title claims abstract description 34
- 235000013305 food Nutrition 0.000 title claims abstract description 28
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 66
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 33
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 33
- 239000007901 soft capsule Substances 0.000 claims abstract description 23
- 229960005375 lutein Drugs 0.000 claims abstract description 16
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 16
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 16
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 14
- 235000013871 bee wax Nutrition 0.000 claims abstract description 14
- 239000012166 beeswax Substances 0.000 claims abstract description 14
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 14
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 14
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 14
- 241000195493 Cryptophyta Species 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 235000012680 lutein Nutrition 0.000 claims description 14
- 239000001656 lutein Substances 0.000 claims description 14
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 235000021388 linseed oil Nutrition 0.000 claims description 9
- 239000000944 linseed oil Substances 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 230000008014 freezing Effects 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 6
- 235000012054 meals Nutrition 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 238000004040 coloring Methods 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 4
- 241000195633 Dunaliella salina Species 0.000 abstract 2
- 235000008210 xanthophylls Nutrition 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 8
- 235000013734 beta-carotene Nutrition 0.000 description 8
- 239000011648 beta-carotene Substances 0.000 description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 8
- 229960002747 betacarotene Drugs 0.000 description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 8
- 239000013589 supplement Substances 0.000 description 7
- 210000001525 retina Anatomy 0.000 description 4
- 229940092738 beeswax Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002189 macula lutea Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a health-care food composition capable of alleviating asthenopia. The health-care food composition consists of the following raw materials of 5-80 parts of a dunaliella salina extract, 20-200 parts of alpha-linolenic acid, 50-300 parts of xanthophyll, 20-110 parts of zinc gluconate and 1-15 parts of beeswax. The invention further relates to a soft capsule. The soft capsule comprises inclusions and soft capsule skins coating the inclusions, wherein the inclusions are the health-care food composition capable of alleviating asthenopia. According to the health-care food composition disclosed by the invention, the dunaliella salina extract, the alpha linolenic acid, the xanthophyll, the zinc gluconate and the beeswax are in cooperation effect, and the composition capable of alleviating asthenopia is purely natural, high in safety and suitable for wide crowds.
Description
Technical field
The present invention relates to a kind of health-care food composition of alleviating asthenopia, the invention still further relates to a kind of using the soft capsule of the health-care food composition of alleviating asthenopia as inclusion.
Background technology
Visual fatigue patient often goes out to lose face dry and astringent, the symptom such as eyelid is heavy, blurred vision, photophobia are shed tears, eye distending pain and eye are congested, also can there is headache in severe patient, dizzy, nauseating, One's spirits are drooping, absent minded, decrease of memory, poor appetite and neck take on aching pain in waist and back and the whole body syndrome such as articulations digitorum manus numbness, directly affects study, operating efficiency and quality of life.Instantly society, visual fatigue is more common in the crowd needing long-term eye operation, but is accustomed to incorrect, the bad illumination of operating environment etc. with eye, also can bring out visual fatigue.
In prior art, constantly occur the product of alleviating asthenopia, but its common shortcoming is: have certain chemical harmful toxic matter, Long-Time Service has certain side effect; And Long-Time Service can make people produce dependence, but not fundamentally alleviate people use kopiopia symptom.
Therefore, be necessary to propose effective technical scheme, solve the problem.
Summary of the invention
The present invention is directed to above-mentioned the deficiencies in the prior art, the health-care food composition of alleviating asthenopia that a kind of pure natural is provided, that have no side effect.
The technical scheme that the present invention solves the problems of the technologies described above is as follows:
A health-care food composition for alleviating asthenopia, its raw material consists of: algae extrats 5-80 part, alpha-linolenic acid 20-200 part, lutein 50-300 part, zinc gluconate 20-110 part, beeswax 1-15 part.
Preferably, its raw material consists of: algae extrats 50-60 part, alpha-linolenic acid 150-200 part, lutein 50-100 part, zinc gluconate 20-50 part, beeswax 1-5 part.
Preferably, its raw material consists of: algae extrats 60 parts, alpha-linolenic acid 200 parts, 50 parts, lutein, zinc gluconate 30 parts, 5 parts, beeswax.
Preferably, described algae extrats obtains through following steps: get salt algae powder and be broken into meal, and add 6 times amount 95% ethanol in meal, soak 12 hours, heating and refluxing extraction 2 hours, leaches extract; By extract by D-101 macroporous resin column, with 1.5mLmin
-1speed loading, purified water is with 1.5BVh
-1wash-out 6BV, collects eluent, and ethanol eluate reclaims ethanol and obtains algae extrats.
Preferably, described alpha-linolenic acid is the high-purity alpha-linolenic acid that purity is at least 90%.
Preferably, described alpha-linolenic acid obtains through following steps: first undertaken ethyl esterified by linseed oil, then obtain alpha-linolenic acid after purifying; Described linseed oil is ethyl esterified is by linseed oil and ethanol under base catalyst, vacuum state condition, 65 DEG C of reactions 3 hours; Described purification is through the crystallization of second order gradient freezing, then obtains alpha-linolenic acid after column chromatography.
Preferably, the crystallization of described second order gradient freezing is down to-15 DEG C from original temperature at the first stage, constant temperature 2h; Second stage is down to-25 DEG C from-15 DEG C, constant temperature 2h, washing and filtering.
The present invention also provides a kind of soft capsule, its soft capsule skin comprising inclusion and be wrapped in inclusion outside, and described inclusion is the health-care food composition of above-mentioned alleviating asthenopia.
Preferably, described soft capsule skin raw material consists of: gelatin 200-500 part, glycerine 40-220 part, purified water 200-500 part, burnt sugar coloring 1-12 part.
Beneficial effect:
Salt algae contains abundant beta carotene, and simultaneously containing mineral matters such as higher Ca, P, Zn, in body, the beta carotene of synthesis can reach more than 10% of dry cell weight, and in carrot, content beta-carotene is only 4/10000ths of dry weight.Beta carotene can make skin and mucosa cells normalization also can maintain the normal function of retina, can supplement cell consumption composition.
Visual cell overruns, and the supply of desired nutritional material not in time, and cause macula lutea and retina to extend recovery time, alpha-linolenic acid can supplement cell consumption composition.
Lutein possesses the activity compared with strong antioxidant action energy inhibit activities oxygen radical, stop active oxygen radical to Normocellular destruction, the a large amount of blue light of lutein Absorbable rod, wavelength and the ultraviolet light of blue visible light are close, are to reach the maximum a kind of light of potential hazard in amphiblestroid visible ray.
The present invention is by the mating reaction of algae extract, alpha-linolenic acid, lutein, zinc gluconate and beeswax, and the composition of the function of relieving visual fatigue of pure natural, security is high, has and is suitable for crowd widely.
Utilize above-mentioned composition as the soft capsule of inclusion, instant, be suitable for crowd extensive.
Detailed description of the invention
The present invention sets about from the Forming Mechanism of visual fatigue, in a kind of preferred embodiment of the present invention, there is provided a kind of health-care food composition of fundamentally alleviating asthenopia, its raw material consists of: algae extrats, alpha-linolenic acid, lutein, zinc gluconate, beeswax.
Wherein, the use of algae extrats is important concerning the health-care food composition of alleviating asthenopia of the present invention.Concrete, described algae extrats obtains through following steps: get salt algae powder and be broken into meal, and add 6 times amount 95% ethanol in meal, soak 12 hours, heating and refluxing extraction 2 hours, leaches extract; By extract by D-101 macroporous resin column, with 1.5mLmin
-1speed loading, purified water is with 1.5BVh
-1wash-out 6BV, collects eluent, and ethanol eluate reclaims ethanol and obtains algae extrats.Salt algae contains abundant beta carotene, and simultaneously containing mineral matters such as higher Ca, P, Zn, in body, the beta carotene of synthesis can reach more than 10% of dry cell weight, and in carrot, content beta-carotene is only 4/10000ths of dry weight.Beta carotene can make skin and mucosa cells normalization also can maintain the normal function of retina, can supplement cell consumption composition.
The use of alpha-linolenic acid is important concerning the health-care food composition of alleviating asthenopia of the present invention.Concrete, described alpha-linolenic acid is the high-purity alpha-linolenic acid that purity is at least 90%, is to obtain through following steps: first undertaken ethyl esterified by linseed oil, then obtains alpha-linolenic acid after purifying; Described linseed oil is ethyl esterified is by linseed oil and ethanol under base catalyst, vacuum state condition, 65 DEG C of reactions 3 hours; Described purification is through the crystallization of second order gradient freezing, then obtains alpha-linolenic acid after column chromatography; The crystallization of described second order gradient freezing is down to-15 DEG C from original temperature at the first stage, constant temperature 2h; Second stage is down to-25 DEG C from-15 DEG C, constant temperature 2h, washing and filtering.Visual cell overruns, and the supply of desired nutritional material not in time, and cause macula lutea and retina to extend recovery time, alpha-linolenic acid can supplement cell consumption composition.
A kind of soft capsule of the present invention, its soft capsule skin comprising inclusion and be wrapped in inclusion outside, described inclusion is the health-care food composition of above-mentioned alleviating asthenopia.
Described soft capsule skin raw material consists of: gelatin 200-500 part, glycerine 40-220 part, purified water 200-500 part, burnt sugar coloring 1-12 part.
Below, by specific embodiment, the health-care food composition of alleviating asthenopia of the present invention and soft capsule are further described.
Embodiment 1
A health-care food composition for alleviating asthenopia, its raw material consists of: algae extrats 60 grams, alpha-linolenic acid 200 grams, 50 grams, lutein, zinc gluconate 30 grams, 5 grams, beeswax.
Embodiment 2
A health-care food composition for alleviating asthenopia, its raw material consists of: algae extrats 10 grams, alpha-linolenic acid 50 grams, 100 grams, lutein, zinc gluconate 30 grams, 5 grams, beeswax.
Embodiment 3
A health-care food composition for alleviating asthenopia, its raw material consists of: algae extrats 50 grams, alpha-linolenic acid 100 grams, 300 grams, lutein, zinc gluconate 100 grams, 15 grams, beeswax.
Embodiment 4
A kind of soft capsule, its soft capsule skin comprising inclusion and be wrapped in inclusion outside, described inclusion is the health-care food composition of the alleviating asthenopia of embodiment 1.Described soft capsule skin raw material consists of: 300 grams, gelatin, glycerine 100 grams, purified water 300 grams, burnt sugar coloring 5 grams.
The preparation method of this soft capsule: by gelatin, glycerine, purified water and burnt sugar coloring in proportion putting into glue pot high steam make capsule shell fluid, utilize conventional method that capsule shell fluid is made soft capsule skin;
Again algae extrats, alpha-linolenic acid, lutein, zinc gluconate, beeswax are stirred in proportion outstanding mixed aqueous capsulation solution, capsulation solution is injected soft capsule skin and make soft capsule.
The present invention supplements cell consumption composition, alleviating asthenopia Be very effective by algae extrats and the dual strengthening of alpha-linolenic acid.As one embodiment of the present of invention, through algae extrats prepared by the inventive method, purity is high, impurity is few, supplements cell consumption composition successful; Through alpha-linolenic acid prepared by the inventive method, purity is high, impurity is few, supplements cell consumption composition successful.
The present invention can summarize with other the concrete form without prejudice to spirit of the present invention or principal character.Therefore, no matter from which point, above-mentioned embodiment of the present invention all can only be thought explanation of the present invention and can not limit the present invention, claims indicate scope of the present invention, and scope of the present invention is not pointed out in above-mentioned explanation, therefore, any change in the implication suitable with claims of the present invention and scope, all should think in the scope of the claims being included in health care pedicure device of the present invention.
Claims (9)
1. a health-care food composition for alleviating asthenopia, is characterized in that, its raw material consists of: algae extrats 5-80 part, alpha-linolenic acid 20-200 part, lutein 50-300 part, zinc gluconate 20-110 part, beeswax 1-15 part.
2. the health-care food composition of alleviating asthenopia as claimed in claim 1, it is characterized in that, its raw material consists of: algae extrats 50-60 part, alpha-linolenic acid 150-200 part, lutein 50-100 part, zinc gluconate 20-50 part, beeswax 1-5 part.
3. the health-care food composition of alleviating asthenopia as claimed in claim 2, it is characterized in that, its raw material consists of: algae extrats 60 parts, alpha-linolenic acid 200 parts, 50 parts, lutein, zinc gluconate 30 parts, 5 parts, beeswax.
4. the health-care food composition of alleviating asthenopia as claimed in claim 3, it is characterized in that, described algae extrats obtains through following steps: get salt algae powder and be broken into meal, add 6 times amount 95% ethanol in meal, soak 12 hours, heating and refluxing extraction 2 hours, leaches extract; By extract by D-101 macroporous resin column, with 1.5mLmin
-1speed loading, purified water is with 1.5BVh
-1wash-out 6BV, collects eluent, and ethanol eluate reclaims ethanol and obtains algae extrats.
5. the health-care food composition of alleviating asthenopia as claimed in claim 3, it is characterized in that, described alpha-linolenic acid is the high-purity alpha-linolenic acid that purity is at least 90%.
6. the health-care food composition of alleviating asthenopia as claimed in claim 5, it is characterized in that, described alpha-linolenic acid obtains through following steps: first undertaken ethyl esterified by linseed oil, then obtain alpha-linolenic acid after purifying; Described linseed oil is ethyl esterified is by linseed oil and ethanol under base catalyst, vacuum state condition, 65 DEG C of reactions 3 hours; Described purification is through the crystallization of second order gradient freezing, then obtains alpha-linolenic acid after column chromatography.
7. the health-care food composition of alleviating asthenopia as claimed in claim 6, it is characterized in that, the crystallization of described second order gradient freezing is down to-15 DEG C from original temperature at the first stage, constant temperature 2h; Second stage is down to-25 DEG C from-15 DEG C, constant temperature 2h, washing and filtering.
8. a soft capsule, is characterized in that, its soft capsule skin comprising inclusion and be wrapped in inclusion outside, the health-care food composition of the alleviating asthenopia of described inclusion according to any one of claim 1 to 7.
9. soft capsule as claimed in claim 8, it is characterized in that, described soft capsule skin raw material consists of: gelatin 200-500 part, glycerine 40-220 part, purified water 200-500 part, burnt sugar coloring 1-12 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510874513.XA CN105341929A (en) | 2015-12-02 | 2015-12-02 | Health-care food composition capable of alleviating asthenopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510874513.XA CN105341929A (en) | 2015-12-02 | 2015-12-02 | Health-care food composition capable of alleviating asthenopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105341929A true CN105341929A (en) | 2016-02-24 |
Family
ID=55318207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510874513.XA Pending CN105341929A (en) | 2015-12-02 | 2015-12-02 | Health-care food composition capable of alleviating asthenopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105341929A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107625795A (en) * | 2017-09-30 | 2018-01-26 | 广州市辉乐医药科技有限公司 | A kind of composition for relieving asthenopia and preparation method thereof |
| CN109222086A (en) * | 2018-09-12 | 2019-01-18 | 无限极（中国）有限公司 | A kind of composition and its application and health food with efficacy of relieving visual fatigue |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103190610A (en) * | 2013-03-18 | 2013-07-10 | 北京博远欣绿科技有限公司 | Double-pigment soft capsule preparation and preparation method |
| CN103242965A (en) * | 2013-05-31 | 2013-08-14 | 烟台燕园科玛生物技术开发有限公司 | Method for extracting and purifying alpha-linolenic acid |
| CN103735616A (en) * | 2014-01-20 | 2014-04-23 | 大连医诺生物有限公司 | Microencapsulated preparation for protecting eyesight and preparation method thereof |
| CN104824675A (en) * | 2015-05-13 | 2015-08-12 | 宁波北仑戌鸿农业科技有限公司 | Eyesight improving lutein capsule |
-
2015
- 2015-12-02 CN CN201510874513.XA patent/CN105341929A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103190610A (en) * | 2013-03-18 | 2013-07-10 | 北京博远欣绿科技有限公司 | Double-pigment soft capsule preparation and preparation method |
| CN103242965A (en) * | 2013-05-31 | 2013-08-14 | 烟台燕园科玛生物技术开发有限公司 | Method for extracting and purifying alpha-linolenic acid |
| CN103735616A (en) * | 2014-01-20 | 2014-04-23 | 大连医诺生物有限公司 | Microencapsulated preparation for protecting eyesight and preparation method thereof |
| CN104824675A (en) * | 2015-05-13 | 2015-08-12 | 宁波北仑戌鸿农业科技有限公司 | Eyesight improving lutein capsule |
Non-Patent Citations (1)
| Title |
|---|
| 虞海天: "《中国优秀硕士学位论文数据库》", 31 December 2014 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107625795A (en) * | 2017-09-30 | 2018-01-26 | 广州市辉乐医药科技有限公司 | A kind of composition for relieving asthenopia and preparation method thereof |
| CN109222086A (en) * | 2018-09-12 | 2019-01-18 | 无限极（中国）有限公司 | A kind of composition and its application and health food with efficacy of relieving visual fatigue |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7179930B2 (en) | Process for isolating, purifying and formulating a stable, commercial grade Lutein paste from oleoresin | |
| EP0666845B1 (en) | Method for purifying beta-carotene | |
| US9622497B2 (en) | Carotenoid oil suspension with high bioavailability and preparation method thereof | |
| US20070032683A1 (en) | Process for isolation and purification of xanthophyll crystals from plant oleoresin | |
| CN101474311A (en) | Soft capsule for alleviating eyestrain and preparation method thereof | |
| CN101514177B (en) | Method for extracting lutein from marigold particles | |
| CN103820270B (en) | Compound raspberry wine provided with biological effect and production method thereof | |
| CN102144780A (en) | Lutein ester health care product for protecting eyesight and preparation method thereof | |
| CN101904502B (en) | Compound xanthophyll soft capsule and preparation method | |
| US8748495B2 (en) | Method of preparing oil suspensions of carotenoid with low viscosity and high fluidity and use thereof | |
| CN102389115A (en) | Health food for alleviating visual fatigue and preparation method and application thereof | |
| CN101283806A (en) | Diet replenisher containing natural carotenol and its preparation technique | |
| CN101890116A (en) | Anthocyanin health-care eye drops and preparation method thereof | |
| CN109805400A (en) | A kind of cowberry lutein health food for alleviating visual fatigue | |
| JP2012525330A (en) | Method for separating carotenoid crystals from various plants | |
| CN105192696A (en) | Composition for protecting eyeground and nutrition retinas and resisting blue light damage and preparation method of composition | |
| CN105341929A (en) | Health-care food composition capable of alleviating asthenopia | |
| CN109430856A (en) | A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue | |
| WO2009027850A2 (en) | Process for the preparation of xanthophyll crystals | |
| CN102584662A (en) | Method for preparing water-soluble lutein | |
| JP2002017295A (en) | Health auxiliary food product having activity for ameliorating eye disease and activity for keeping function of eye | |
| CN107550894A (en) | The purposes of lutein is extracted from marigold | |
| KR101769987B1 (en) | Pharmaceutical composition for the prevention and treatment of disease by blue light comprising Spirulina maxima as an active ingredient | |
| CN101869296A (en) | Nutrition capsules for treating senile maculopathy and preparation process | |
| CN100400038C (en) | Compound soft lutein capsule and its prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |